Ledger.Open graph →
SEC Form D · filed December 24, 2014

Novira Therapeutics, Inc

Offering
$9.0M
Sold
$9.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DOYLESTOWN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Tim M. Shannon · Westport, CTDirectorGeorge M. Hartman · Doylestown, PAExecScott M. Rocklage · Menlo Park, CADirectorOsvaldo S. Flores · Doylestown, PAExecAnthony M. Ford-Hutchinson · Doylestown, PADirectorChristian S. Schade · Doylestown, PAExec · DirectorGianni M. Gromo · San Francisco, CADirectorNathaniel M. Brown · Doylestown, PAExecKlaus M. Klumpp · Doylestown, PAExecDouglas S. Carr · Doylestown, PAExecHoward S. Garfield · Addison, TXDirectorRobert T. Poynter · Addison, TXDirectorRon C. Foster · Fayetteville, ARExecGreg C. Lee · Fayetteville, ARExecScott M. Rocklage · Menlo Park, CADirectorChristian S. Schade · Doylestown, PAExec · DirectorNathaniel M. Brown · Doylestown, PAExecGianni M. Gromo · San Francisco, CADirectorKlaus M. Klumpp · Doylestown, PAExecDouglas S. Carr · Doylestown, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗